TOG 1119: Phase II randomized study of whole brain radiotherapy with concurrent lapatinib in patients with brain metastasis from HER2-positive breast cancer-A collaborative study of RTOG and KROG (NCT01622868)
Conference
Peereboom, David M, Winter, Kathryn A, Kim, In Ah et al. (2014). TOG 1119: Phase II randomized study of whole brain radiotherapy with concurrent lapatinib in patients with brain metastasis from HER2-positive breast cancer-A collaborative study of RTOG and KROG (NCT01622868)
. JOURNAL OF CLINICAL ONCOLOGY, 32(15), 10.1200/jco.2014.32.15_suppl.tps664
Peereboom, David M, Winter, Kathryn A, Kim, In Ah et al. (2014). TOG 1119: Phase II randomized study of whole brain radiotherapy with concurrent lapatinib in patients with brain metastasis from HER2-positive breast cancer-A collaborative study of RTOG and KROG (NCT01622868)
. JOURNAL OF CLINICAL ONCOLOGY, 32(15), 10.1200/jco.2014.32.15_suppl.tps664